DRL
Location
Vlaams Brabant
Founded
1980-09-05
Website
Risk Signals
106 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Catalog and Mail-Order Houses), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DRL
Live alerts from global media, monitored by Business Radar
2025-01-24 (business-standard.com)
Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects
Analysts at HDFC Securities stated that beyond Revlimid, there is not enough immediate pipeline to sustain growth and margin momentum for DRL. The brokerage...
Read more
2021-07-08 (moneycontrol.com)
How Erez Israeli revived Dr Reddy's by focusing on costs and non-US markets
Erez Israeli who took over as chief executive officer of DRL in 2019 sharpened its focus on costs and execution. Its recovery holds a lesson or two for major drug firms
Read more
(economictimes.com)
Dr Reddy's Labs, Mankind Pharma riding on strong growth drivers -
Indian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter. Dr. Reddy's achieved this milestone despite challenges in Europe and increased expenses, while Mankind Pharma thrived on robust domestic sales and expansion into consumer healthcare. Both companies remain optimistic about future prospects.
Read more